You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

404 Results
Blog post
In any given year, one in five Canadians will suffer from a mental health problem. For people living with cancer and their families, the risk is...
Aug 2019
Document
Sep 2019
Document
Sep 2019
Document
Sep 2019
Document
Oct 2019
Drug
Other Name(s): Erwinase®
Quick Link(s):
Drug Monograph
Jan 2020
Document
Nov 2019
Guidelines and Advice
Status: Current
ID: pet 2019-1
Version: N/A
Nov 2019
Drug
Other Name(s): Unituxin®
Quick Link(s):
Drug Monograph
Jun 2023
Regimen
Cancer Type:
Genitourinary, 
Prostate
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    darolutamide - For the treatment of high risk non-metastatic castration resistant prostate cancer (nmCRPC), based on criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
darolutamide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2025
Document
Mar 2020
Statistical Reports

Pages